Mentholatum’s Iron Man pain relief
NEW YORK Compared with the facings currently in the category, Mentholatum’s Iron Man triple action muscle and joint roll on pain relief really stands out as the external pain relief for the active weekend warrior.
CVS Caremark Charitable Trust supports flood relief efforts
WOONSOCKET, R.I. The CVS Caremark Charitable Trust is donating $100,000 to the American Red Cross Disaster Relief Fund to support flood relief efforts in the southeastern United States, including the states of Alabama, Mississippi and Tennessee.
In addition to the cash donation, the foundation is donating more than $13,000 in food and personal care items to the Seventh Day Adventist Center in Albertville, Ala., and the American Red Cross in Nashville. The donated product will be distributed to flood victims in these local communities.
“The Red Cross has implemented a coordinated effort to assist victims of these devastating floods and we are committed to supporting their efforts across the states that are impacted,” stated Eileen Howard Dunn, VP of the CVS Caremark Charitable Trust. “It is our hope that these funds will help these communities recover as quickly as possible.”
Keryx enrolls patients in Zerenex trial
NEW YORK Keryx Biopharmaceuticals has started a late-stage clinical trial of a drug for patients on kidney dialysis, the drug maker said Thursday.
Keryx plans to enroll around 150 people for a phase 3 trial of Zerenex (ferric citrate), a treatment for patients on kidney dialysis with elevated serum phosphorous levels, also known as hyperphosphatemia. The company started the short-term efficacy study Thursday and plans to start the long-term safety and efficacy study in third quarter 2010.
“I am pleased to be leading the registration program for Zerenex,” study chairwoman and Vanderbilt University medicine professor Julia Lewis said. “The clinical data generated to date suggests that Zerenex is an effective, safe and well-tolerated phosphate binder which we expect is differentiated form other marketed therapies by its iron composition and potential dosing convenience.”